SG Dealbook: QT Vascular raises funds; UMS, OCBC, Soo Kee make investments

By
Posted

Lion Global Investors, an OCBC subsidiary, has increased its holding in China’s Maxwealth Fund Management Company to 28.51% from 10% earlier.

OCBC

China Digest: Aqrose, Mall Parking, SinoUnited Health, Daily Yoga, Yawlih raise funds

By

Baidu Ventures and DCM China have co-led an $8-million Series A round in Aqrose Technology.


Singapore’s Temasek leads $100m Series C in Chinese robotics startup Rokid

By

The funding round in Rokid was also joined by Credit Suisse Group, CDIB Capital International, and existing investor IDG Capital.


SoftBank leads $1b funding in Ping An healthcare unit ahead of Hong Kong IPO

By

The round values the unit at $8.8b and also attracted Japan’s SBI Holdings as a lead investor.


India: Vedanta may also join Hindalco in race for Aleris Corp

By

Earlier this month Hindalco Industries had made a non-binding offer for Aleris through its US unit Novelis Inc. 


India: Infosys’ sour M&A deals pose challenge for new CEO Salil Parekh

By

The firm has shut down Noah Consulting, the company it bought for $70 million in 2015.


Toshiba agrees to sell Westinghouse assets, bolstering capital by $3.68b

By

The sale will end the Toshiba’s troubled foray into overseas nuclear power, which started with the $5.4 billion acquisition of Westinghouse in 2006.


U.S. okays Chinese semiconductor deal in surprise move by CFIUS

By

Beijing-based Naura Microelectronics has completed a deal to buy U.S. semiconductor manufacturing equipment company Akrion Systems LLC


India: IFC to invest $150m debt in Aditya Birla Finance

By

IFC’s financing will help ABFL with long-tenor funding – up to 7 years – which is important for it to expand its ability to fund renewable energy projects. The proceeds shall be used by ABFL to fund solar projects in select states of India.


Chinese bidders evince interest in Johnson & Johnson’s diabetes biz in potential $3-4b deal

By

The market for diabetes care in China is expected to grow rapidly. Almost one in three of the world’s diabetes sufferers lives in China.